Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns.

Kreuter M Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg (TLRCH), member of the German Center for Lung Research (DZL), Heidelberg, Germany kreuter@uni-heidelberg.de.
Wijsenbeek MS Dept of Pulmonary Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands.
Vasakova M Dept of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.
Spagnolo P Medical University Clinic, Canton Hospital Baselland and University of Basel, Liestal, Switzerland.
Kolb M Firestone Institute for Respiratory Health, Dept of Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Costabel U Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany.
Weycker D Policy Analysis Inc. (PAI), Brookline, MA, USA.
Kirchgaessler KU F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Maher TM National Institute for Health Research Biomedical Research Unit, Royal Brompton Hospital, London, UK.